期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

血清淀粉样蛋白A的研究进展 被引量：17

Advances in Research into Serum Amyloid A
下载PDF
导出
摘要 血清淀粉样蛋白A(SAA)是一个非常敏感的急性相反应物。不管是在健康人还是在患有冠状动脉疾病的人群中,SAA、C反应蛋白等炎症反应物均能预测心血管事件发生的危险几率。 Serum amyloid A （SAA） is a sensitive reactant in the acute phase. SAA, C-reactive protein and other inflammatory reactants may prognosticate the risk rate of cardiovascular events in healthy people and events in patients with coronary heart disease.
作者 朱华 王娟 林燕 张芃 刘家民
机构地区 山东省职业卫生与职业病防治研究院 山东省医学科学院抗衰老研究中心
出处 《心血管病学进展》 CAS 2007年第1期113-115,共3页 Advances in Cardiovascular Diseases
关键词 淀粉样蛋白A 冠心病 serum amyloid A coronary artery disease
分类号 R543 [医药卫生—心血管疾病]
  • 相关文献

参考文献21

  • 1刘钢,王兰兰,李立新,武永康,王玲,王忠明,谢其冰.血清淀粉样蛋白A——类风湿关节炎的一个炎性指标[J].中华风湿病学杂志,2002,6(2):108-110. 被引量：9
  • 2Uhlar CM,Whitehead AS.Serum amyloid A,the major vertebrate acute-phase reactant[J].Eur J Biochem,1999,265(2):501-523.
  • 3Urieli-Shoval S,Linke RP,Matzner Y.Expression and function of serum amyloid A,a major acute phase protein,in normal and disease states[J].Curr Opin Hematol,2000,7:64-69.
  • 4胡波,梁家隐,周新.类风湿性关节炎患者IL-1β、IL-6及SAA水平的变化及其临床意义[J].华中医学杂志,2000,24(6):287-288. 被引量：9
  • 5Wang L,Colon W.The interaction between apolipoprotein serum amyloid A and high-density lipoprotein[J].Biochem Biophys Res Commun,2004,317(1):157-161.
  • 6Chait A,Lewis K,Tannock L,et al.Nutrition and inflammation:Role of dietary cholesterol[J].Int Congress Series,2004,1262:313-316.
  • 7Ogasawara K,Mashiba S,Wada Y,et al.A serum amyloid A and LDL complex as a new prognostic marker in stable coronary artery disease[J].Atherosclerosis,2004,174:349-356.
  • 8Jousilahti P,Salomaa V,Rasi V,et al.The association of C-reactive protein,serum amyloid A and fibrinogen with prevalent coronary heart disease-baseline findings of the PAIS project[J].Atherosclerosis,2001,156:451-456.
  • 9吴海云,王士雯,朱姝,许强.川芎嗪在急性冠状动脉综合征中抗炎作用的研究[J].中国中西医结合急救杂志,2004,11(4):196-198. 被引量：23
  • 10Delanghe JR,Langlois MR,Bacquer DD,et al.Discriminative value of serum amyloid A and other acute-phase proteins for coronary heart disease[J].Atherosclerosis,2002,160:471-476.

二级参考文献36

  • 1Song J X,Ruan Q R.Mechanism of ligustrazini against throm-bosis[J].Chin Med J,2000,113 (2):136-139.
  • 2Morrow D A,Rafai N,Antman E M,et al.Serum amyloid A predicts early mortality in acute coronary syndromes:a TIMI 11A substudy[J].J Am Coll Cardiol,2000,35:358-364.
  • 3Zeng Z,Zhu W,Zhou X,et al.Mechanisms involved in the antiplatelet activity of tetramethylpyrazine in human platelets[J].J Cardiovasc Pharmacol,1998,31 Suppl 1:S313-S316.
  • 4Zhang Z H,Yu S Z,Wang Z T.Scavenging effects of tetrame-thylpyrazine on active oxygen free radicals[J].Acta Pharmacol Sinica,1994,15(3):229-231.
  • 5Morrow D A,Rafai N,Antman E M,et al.C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes:a TIMI 11A substudy[J].J Am Coll Cardiol,1998,31:1460-1465.
  • 6Ozaki Y.Antiinflammatory effect of tetramethylpyrazine and ferulic acid[J].Chem Pharm Bull (Tokyo),1992,40(4):954-956.
  • 7Zhang Z,Wei T,Hou J,et al.Tetramethylpyrazine scavenges superoxide anion and decreases nitric oxide production in human polymorphonuclear leukocytes[J].Life Sci,2003,72(22):2465-2472.
  • 8Collet J P,Montalescot G,Vicaut E,et al.Acute release of plasminogen activator inhibitor-1 in ST-segment elevation myocardial infarction predicts mortality[J].Circulation,2003,108:391-394.
  • 9Vaughan D E,Declerck P J,Van Houtte E,et al.Reactivated recombinat plasminogen activator inhibitor-1 (rPAI-1) effectively prevents thrombolysis in vivo[J].Thromb Haemost,1992,68:60-63.
  • 10Cannon C P,McCabe C H,Wilcox R G,et al.Oral glycoprotein Ⅱb/Ⅲa inhibition with orbofiban in patients with unstable coronary syndromes (OPUSTIMI 16) trial[J].Circulation,2000,102:149-156.

共引文献42

同被引文献123

引证文献17

二级引证文献194

心血管病学进展
2007年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部